Product Details:
| Minimum Order Quantity | 1 Piece |
| Delivery Device Type | Pen |
| Brand | Osteri |
| Manufacturer | Emcure |
| Treatment | Osteoporosis |
| Strength | 600 mcg |
| Packaging Type | Box |
| Form | Injection |
| Composition | Teriparatide |
| Pack Size | 2.4ml |
Additional Information:
Product Details:
| Delivery Device Type | Pen |
| Brand | Bonista PF |
| Manufacturer | Ortholands |
| Treatment | Osteoporosis |
| Strength | 600 mcg |
| Packaging Type | Box |
| Composition | Teriparatide |
| Pack Size | 2.4ml |
Product Details:
| Treatment | Osteoporosis |
| Manufacturer | Zydus |
| Brand | Bonmax |
| Packaging Size | 3ml |
| Packaging Type | Cartridge |
| Strength | 750 mcg |
| Form | Injection |
| Composition | Teriparatide 750mcg |
Bonmax PTH 750mcg Injection (containing Teriparatide) is a synthetic parathyroid hormone used to treat severe osteoporosis in postmenopausal women and men at high risk of fractures by stimulating new bone formation. It is administered via subcutaneous injection into the thigh or abdomen, usually for a maximum of 24 months.
Product Details:
| Strength | 600 mcg |
| Packaging Type | Vial |
| Packaging Size | 2.4 ml |
| Brand | Bonista |
| Composition | Teriparatide |
| Form | Injection |
| Treatment | To treat severe osteoporosis in postmenopausal women and men at high risk of fractures |
Bonista 600mcg/2.4mL Teriparatide Injection is a synthetic parathyroid hormone used to treat severe osteoporosis in postmenopausal women and men at high risk of fractures. It stimulates bone formation, increasing bone mineral density (BMD) and strength, specifically reducing spinal and hip fractures. It is also indicated for glucocorticoid-induced osteoporosis. It is administered daily via subcutaneous injection (usually into the thigh or stomach) for a maximum of 2 years.